XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Income and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues $ 85,531 $ 82,460
Cost of Products Sold 59,299 57,352
Gross Profit 26,232 25,108
Operating Expenses:    
Research and Development 4,737 5,946
Selling, General and Administrative 15,019 15,399
Total Operating Expenses 19,756 21,345
Operating Income 6,476 3,763
Other Expense (Income):    
Interest and Financing Expense 183 263
Miscellaneous (2) (80)
Income Before Income Taxes 6,295 3,580
Income Tax (Benefit) Provision (1,369) 98
Net Income 7,664 3,482
Net Income (Loss) Attributable to Non-Controlling Interest 16 (27)
Net Income Attributable to Ultralife Corporation 7,648 3,509
Other Comprehensive Income (Loss):    
Foreign Currency Translation Adjustments 1,469 (2,173)
Comprehensive Income Attributable to Ultralife Corporation $ 9,117 $ 1,336
Net Income Per Share Attributable to Ultralife Corporation Common Shareholders – Basic: (in dollars per share) $ 0.49 $ 0.23
Net Income Per Share Attributable to Ultralife Corporation Common Shareholders – Diluted: (in dollars per share) $ 0.48 $ 0.23
Weighted Average Shares Outstanding – Basic (in shares) 15,528 15,261
Weighted Average Shares Outstanding – Diluted (in shares) 15,858 15,405